American International Group, Inc. Graphite Bio, Inc. Call Options Transaction History
American International Group, Inc.
- $8.5 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GRPH
# of Institutions
3Shares Held
637KCall Options Held
0Put Options Held
0About Graphite Bio, Inc.
- Ticker GRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,211,200
- Description
- Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...